Mirfin Mpundu

Mirfin Mpundu is a member of the Expert Committee for the 2026 Antimicrobial Resistance Benchmark. Mirfin is the Executive Director of ReAct Africa where he is responsible for strategic leadership in implementing ReAct’s strategic plan and activities in Africa, building partnerships with other stakeholders including governments, supporting translation of evidence into policies, contributing to regional and global governance and catalysing action to address AMR. Mirfin previously served as the Africa Lead for Partnerships & Stakeholder Engagement at the International Centre for Antimicrobial Resistance Solutions (ICARS) for four years.

Mirfin is a public health specialist with over 25 years extensive experience in global health. His work on AMR has included supporting countries with AMR National Action Plan development and implementation, as well as providing provision of technical support to WHO, FAO, OIE, Africa CDC and Southern Africa Development Community (SADC) on AMR strategies and policies. He has also worked as a clinical pharmacist and worked with faith-based institutions across sub-Saharan African countries.

Mirfin's pharmaceutical experience includes pharmaceutical systems strengthening, pharmaceuticals and health technologies, pharmaceutical supply chain management, pharmaceutical policy, regulatory policy and pooled procurement. He has also supported health systems in health care delivery and strategic development.